Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathways between COVID-19 public health responses and increasing overdose risks: A rapid review and conceptual framework
Tribesty Nguyen, Jane A. Buxton
International Journal of Drug Policy (2021) Vol. 93, pp. 103236-103236
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Patterns and motivations of polysubstance use: a rapid review of the qualitative evidence
Michèle Boileau-Falardeau, Gisèle Contreras, Geneviève Gariépy, et al.
Health Promotion and Chronic Disease Prevention in Canada (2022) Vol. 42, Iss. 2, pp. 47-59
Open Access | Times Cited: 41
Overdose deaths and the COVID‐19 pandemic in British Columbia, Canada
Heather Palis, Marc‐André Bélair, Kevin Hu, et al.
Drug and Alcohol Review (2021) Vol. 41, Iss. 4, pp. 912-917
Closed Access | Times Cited: 49
Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada
Marilou Gagnon, Katherine Rudzinski, Adrian Guţă, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
Cardiac Arrest Following Drug Overdose in the United States: An Analysis of the Cardiac Arrest Registry to Enhance Survival
Aditya C. Shekhar, Brian H. Nathanson, Timothy J. Mader, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 7
The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study
Joe Schofield, Joshua Dumbrell, Catriona Matheson, et al.
BMC Public Health (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 26
A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives
Tom May, Jo Dawes, Daisy Fancourt, et al.
International Journal of Drug Policy (2022) Vol. 106, pp. 103752-103752
Open Access | Times Cited: 25
“It’s just a perfect storm”: Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances
Annie Foreman-Mackey, Jessica Xavier, Jenny Corser, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 15
The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months
Alex S. Bennett, Tarlise Townsend, Luther Elliott
International Journal of Drug Policy (2021) Vol. 101, pp. 103554-103554
Open Access | Times Cited: 29
Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada
Nanor Minoyan, Stine Bordier Høj, Camille Zolopa, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 20
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions
Zachary Bouck, Ayden I. Scheim, Tara Gomes, et al.
International Journal of Drug Policy (2022) Vol. 104, pp. 103680-103680
Open Access | Times Cited: 20
Urgent and long overdue: legal reform and drug decriminalization in Canada
Vanessa Gruben, Elaine Hyshka, Matthew Bonn, et al.
FACETS (2024) Vol. 9, pp. 1-28
Open Access | Times Cited: 4
“Basically every safety protocol we have in place to protect against overdose, parents can't access”: Mothers who use unregulated drugs’ experiences of dual public health emergencies
Jade Boyd
International Journal of Drug Policy (2025) Vol. 137, pp. 104719-104719
Open Access
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023
Gráinne Cousins, Louise Durand, Kathleen Bennett, et al.
HRB Open Research (2025) Vol. 8, pp. 32-32
Open Access
Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015–2022
Eshan U. Patel, Jacqueline E. Rudolph, Kenneth A. Feder, et al.
International Journal of Drug Policy (2025) Vol. 138, pp. 104746-104746
Closed Access
Impact of guidance issued during COVID-19 to expand take-home doses of opioid agonist treatment (OAT) in Ireland: protocol for a population-based analysis of prescribing practices and patient outcomes 2018 to 2023
Gráinne Cousins, Louise Durand, Kathleen Bennett, et al.
HRB Open Research (2025) Vol. 8, pp. 32-32
Open Access
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
The Impact of the COVID-19 Pandemic on Opioid-Related Harm in Ontario
Erik Loewen Friesen, Paul Kurdyak, T.C.A. Gomes, et al.
(2021)
Closed Access | Times Cited: 25
Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation
Lisa Frueh, Alexandra B. Collins, Roxxanne Newman, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 10
Volatile drug use and overdose during the first year of the COVID-19 pandemic in the United States
Kristin E. Schneider, Emily Martin, Sean T. Allen, et al.
International Journal of Drug Policy (2024) Vol. 126, pp. 104371-104371
Closed Access | Times Cited: 3
Police officers’ knowledge, understanding and implementation of the Good Samaritan Drug Overdose Act in BC, Canada
Jessica Xavier, Alissa Greer, Alexis Crabtree, et al.
International Journal of Drug Policy (2021) Vol. 97, pp. 103410-103410
Open Access | Times Cited: 21
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the COVID-19 pandemic: A national Delphi study
Louise Durand, Eamon Keenan, Fiona Boland, et al.
International Journal of Drug Policy (2022) Vol. 106, pp. 103768-103768
Open Access | Times Cited: 14
The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
Mercy Ude, Czarina N. Behrends, Shea Kelly, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: A multi-cohort study
Marianna K. Baum, Javier Tamargo, Janet Diaz‐Martinez, et al.
Drug and Alcohol Dependence (2021) Vol. 231, pp. 109230-109230
Open Access | Times Cited: 18
Opioid overdose prevention education in Texas during the COVID-19 pandemic
Charles W. Mathias, Diana M. Cavazos, Kelly McGlothen‐Bell, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 7
The Increase in Addiction during COVID-19
Theodoros Daglis
Encyclopedia (2021) Vol. 1, Iss. 4, pp. 1257-1266
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top